7-150948471-A-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP6BS2_Supporting
The NM_000238.4(KCNH2):āc.2665T>Gā(p.Leu889Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000403 in 1,611,024 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000238.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCNH2 | NM_000238.4 | c.2665T>G | p.Leu889Val | missense_variant | Exon 11 of 15 | ENST00000262186.10 | NP_000229.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNH2 | ENST00000262186.10 | c.2665T>G | p.Leu889Val | missense_variant | Exon 11 of 15 | 1 | NM_000238.4 | ENSP00000262186.5 | ||
KCNH2 | ENST00000330883.9 | c.1645T>G | p.Leu549Val | missense_variant | Exon 7 of 11 | 1 | ENSP00000328531.4 | |||
KCNH2 | ENST00000684241.1 | n.3498T>G | non_coding_transcript_exon_variant | Exon 9 of 13 |
Frequencies
GnomAD3 genomes AF: 0.0000527 AC: 8AN: 151748Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000846 AC: 21AN: 248304Hom.: 0 AF XY: 0.0000891 AC XY: 12AN XY: 134608
GnomAD4 exome AF: 0.0000391 AC: 57AN: 1459276Hom.: 0 Cov.: 37 AF XY: 0.0000372 AC XY: 27AN XY: 726094
GnomAD4 genome AF: 0.0000527 AC: 8AN: 151748Hom.: 0 Cov.: 31 AF XY: 0.0000405 AC XY: 3AN XY: 74128
ClinVar
Submissions by phenotype
not provided Uncertain:2
The L889V variant of uncertain significance in the KCNH2 gene has not been published as pathogenic or been reported as benign to our knowledge. This variant has been identified independently and/or in conjunction with additional cardiogenetic variants in several unrelated individuals referred for genetic testing at GeneDx. So far, segregation data is limited or absent for these individuals. The L889V variant is observed in 21/273922 (0.01%) alleles from individuals of multiple ethnic backgrounds in large population cohorts (Lek et al., 2016). The L889V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. In-silico analyses, including protein predictors and evolutionary conservation, support that this variant does not alter protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is pathogenic or rare benign. -
Testing for our patient was done at GeneDx. Given the lack of case data and its presence at a relatively high minor allele frequency in one subpopulation, we consider this variant a variant of uncertain significance, likely benign and we do not feel it is suitable for assessing risk in healthy relatives ("predictive genetic testing"). This variant has not been reported in the literature, to our knowledge. According to the test report: "The L889V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues sharesimilar properties. Furthermore, in silico analysis is inconsistent in its predictions as to whether or not the variant isdamaging to the protein structure/function." The Leucine at codon 889 is conserved across species, as are neighboring amino acids. The variant was reported online in 20 of 124,642 individuals in the Genome Aggregation Consortium Dataset (gnomAD; http://gnomad.broadinstitute.org/), which currently includes variant calls on >140,000 unrelated individuals of African, Asian, European, Ashkenazi, Latino descent. Specifically, the variant was observed in 13 of 4931 individuals of Ashkenazi Jewish descent (0.13% MAF), 4 of 55,513 individuals of European (non-Finnish) descent (0.0036% MAF) and 3 of 3161 individuals of "other" descent (0.0475% MAF). The phenotype of those individuals is not publicly available. The dataset is comprised of multiple cohorts, some of which were recruited from the general population, others were enriched for common cardiovascular disease. Note that other variants with strong evidence for pathogenicity have been seen at similar frequencies in datasets like this so this does not necessarily rule out pathogenicity (Pan et al 2012). -
Long QT syndrome Uncertain:1Benign:1
This missense variant replaces leucine with valine at codon 889 of the KCNH2 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 22/279536 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
- -
Short QT syndrome type 1;C3150943:Long QT syndrome 2 Uncertain:1
- -
Cardiac arrhythmia Uncertain:1
This missense variant replaces leucine with valine at codon 889 of the KCNH2 protein. Computational prediction tools indicate that this variant's impact on protein structure and function is inconclusive. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with KCNH2-related disorders in the literature. This variant has been identified in 22/279536 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at